Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorogenic acid in impaired glucose tolerance
NCT02621060Phase 2Completed
- Sponsor
- Universidad de Guadalajara
- Start
- Sep 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chlorogenic acid in impaired glucose tolerance (IGT), sponsored by Universidad de Guadalajara. Started Sep 2015; status: completed.
02
Drugs
chlorogenic acid
03
Conditions
impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT02621060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02621060.